Crossmark

Equity in cancer care: mixed methods clinical utility analysis of the Nursing Equity Assessment Tool (NEAT) to identify disadvantage in newly diagnosed cancer patients

Crossref DOI link: https://doi.org/10.1007/s00520-024-09094-x

Published Online: 2024-12-30

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chung, Holly https://orcid.org/0000-0003-1608-4213
Crone, Elizabeth https://orcid.org/0000-0002-2705-7459
Gough, Karla https://orcid.org/0000-0003-2819-4217
Hyatt, Amelia https://orcid.org/0000-0003-2322-7817
Milne, Donna https://orcid.org/0000-0002-9874-2023
Krishnasamy, Meinir https://orcid.org/0000-0002-3050-4213
Funding

Funding for this research was provided by:

Perpetual IMPACT
License Information

Text and Data Mining valid from 2024-12-30

Version of Record valid from 2024-12-30
More Information

Article History

Received: 3 July 2024

Accepted: 10 December 2024

First Online: 30 December 2024

Declarations

:

: This project was reviewed and approved by Peter MacCallum Cancer Centre Human Research Ethics Committee (HREC) (multi-site approval number: HREC/81983/PMCC). All study participants gave informed written consent after the purpose of the study, and their involvement was explained to them. All transcripts were de-identified, and participants were referred to by code numbers rather than names to ensure confidentiality. The methods employed by this study are in accordance with the principles and standards in the Declaration of Helsinki.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below